PLA2G6 Protein (iPLA2-VI)
Overview
PLA2G6, encoding the calcium-independent phospholipase A2 (iPLA2-VI), is a critical enzyme involved in lipid metabolism and cellular homeostasis. The protein is encoded by the PLA2G6 gene located on chromosome 22q13.1 and consists of 1,447 amino acids, forming a catalytically active enzyme belonging to the phospholipase A2 superfamily. iPLA2-VI functions as an intracellular lipase with broad substrate specificity, catalyzing the hydrolysis of the sn-2 acyl bond of phospholipids in a calcium-independent manner. Mutations in PLA2G6 are associated with several severe neurodegenerative disorders, making this protein a central subject in neurodegeneration research.
Function/Biology
iPLA2-VI catalyzes the release of lysophospholipids and free fatty acids from membrane phospholipids through hydrolysis at the sn-2 position. This enzyme operates independently of calcium, distinguishing it from calcium-dependent phospholipases (cPLA2). The protein contains an N-terminal ankyrin repeat domain and catalytic patatin-like domain characteristic of the patatin phospholipase superfamily. iPLA2-VI localizes to multiple cellular compartments including mitochondria, endoplasmic reticulum, peroxisomes, and the inner nuclear membrane, allowing it to regulate lipid composition across distinct membrane systems.
...PLA2G6 Protein (iPLA2-VI)
Overview
PLA2G6, encoding the calcium-independent phospholipase A2 (iPLA2-VI), is a critical enzyme involved in lipid metabolism and cellular homeostasis. The protein is encoded by the PLA2G6 gene located on chromosome 22q13.1 and consists of 1,447 amino acids, forming a catalytically active enzyme belonging to the phospholipase A2 superfamily. iPLA2-VI functions as an intracellular lipase with broad substrate specificity, catalyzing the hydrolysis of the sn-2 acyl bond of phospholipids in a calcium-independent manner. Mutations in PLA2G6 are associated with several severe neurodegenerative disorders, making this protein a central subject in neurodegeneration research.
Function/Biology
iPLA2-VI catalyzes the release of lysophospholipids and free fatty acids from membrane phospholipids through hydrolysis at the sn-2 position. This enzyme operates independently of calcium, distinguishing it from calcium-dependent phospholipases (cPLA2). The protein contains an N-terminal ankyrin repeat domain and catalytic patatin-like domain characteristic of the patatin phospholipase superfamily. iPLA2-VI localizes to multiple cellular compartments including mitochondria, endoplasmic reticulum, peroxisomes, and the inner nuclear membrane, allowing it to regulate lipid composition across distinct membrane systems.
The enzyme participates in several key biological processes: remodeling of membrane phospholipids to maintain optimal fluidity and function, generation of bioactive lipid mediators including lysophospholipids and arachidonic acid, regulation of autophagy and mitophagy through lipid signaling, and modulation of calcium homeostasis. In neurons, these functions are particularly critical for maintaining synaptic integrity, mitochondrial health, and neuronal survival. iPLA2-VI expression is notably high in the nervous system, reflecting the tissue-specific vulnerability of neurons to PLA2G6 dysfunction.
Role in Neurodegeneration
Mutations in PLA2G6 cause several neurodegenerative disorders collectively known as PLA2G6-associated neurodegeneration (PLAN). The most common presentation is Infantile Neuroaxonal Dystrophy (INAD), characterized by progressive neuronal deterioration beginning in infancy. Other manifestations include Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN), Adult-Onset Dystonia-Parkinsonism (ADPD), and axonal neuropathy. The common pathological feature across these conditions is accumulation of iron and lipid deposits in affected neurons, particularly in the basal ganglia, along with progressive axonal degeneration.
Loss-of-function mutations impair iPLA2-VI's ability to maintain lipid homeostasis, leading to abnormal lipid accumulation and membrane dysfunction. This results in compromised mitochondrial function, impaired autophagy and mitophagy, increased oxidative stress, and ultimately neuronal death. The selective vulnerability of specific neuronal populations—particularly those with high metabolic demands—suggests that neurons are uniquely dependent on iPLA2-VI's lipid regulatory functions.
Molecular Mechanisms
PLA2G6 dysfunction triggers multiple pathological cascades in neurons. The impaired remodeling of mitochondrial membranes leads to respiratory chain dysfunction, reduced ATP production, and increased mitochondrial reactive oxygen species generation. Defective autophagy and mitophagy result from altered lipid signaling, causing accumulation of damaged organelles and protein aggregates. Disrupted lipid turnover contributes to membrane rigidity and impaired fluidity, compromising synaptic transmission and neuronal transport.
Pathological iron accumulation in affected neurons likely results from impaired iron homeostasis through defective lipid signaling pathways. Accumulated iron catalyzes formation of reactive oxygen species via Fenton chemistry, exacerbating oxidative damage. Additionally, iPLA2-VI dysfunction affects synthesis of cardiolipin, a critical inner mitochondrial membrane phospholipid essential for optimal oxidative phosphorylation, further impairing energy metabolism.
Clinical/Research Significance
Understanding PLA2G6 mechanisms has illuminated the critical role of lipid homeostasis in neuronal survival. Therapeutic approaches under investigation include antioxidant strategies, iron chelation, mitochondrial function enhancement, and autophagy modulation. Gene therapy approaches targeting PLA2G6 mutations represent promising avenues for treatment. Research continues to elucidate how tissue-specific expression patterns and compensatory mechanisms determine disease phenotype and severity.
- Phospholipase A2 superfamily
- Mitochondrial membrane dynamics
- Autophagy and mitophagy
- Iron metabolism in the nervous system
- Neuraxonal dystrophies
- Lipid signaling pathways
- Oxidative stress and neurodegeneration
Pathway Diagram
The following diagram shows the key molecular relationships involving PLA2G6 Protein (iPLA2-VI) discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)